Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Journal of Experimental Biology|April 20, 2010
Use it or lose it? Sablefish, Anoplopoma fimbria, a species representing a fifth teleostean group where the betaNHE associated with the red blood cell adrenergic stress response has been secondarily lostJodie L Rummer, Mani Roshan-Moniri, Shannon K Balfry, et al.Cancer Treatment Reviews|December 3, 2014
Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancersMani Roshan-Moniri, Michael Hsing, Miriam S Butler, et al.Cytotechnology|January 21, 2014
Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA)Mani Roshan Moniri, Ada Young, Kelsey Reinheimer, et al.Medicine and Science in Sports and Exercise|April 12, 2017
Angiopoietin-like 4 Enhances the Proliferation and Migration of Tendon FibroblastsSarwat Jamil, Rouhollah Mousavizadeh, Mani Roshan-Moniri, et al.Journal of Cellular Physiology|May 8, 2016
Transcriptome-Based Analysis of Molecular Pathways for Clusterin Functions in Kidney CellsGhida Dairi, Qiunong Guan, Mani Roshan-Moniri, et al.The Journal of Biological Chemistry|August 3, 2014
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancerKush Dalal, Mani Roshan-Moniri, Aishwariya Sharma, et al.Oncotarget|February 4, 2016
Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environmentElham Hosseini-Beheshti, Wendy Choi, Louis-Bastien Weiswald, et al.Cancer Letters|August 31, 2018
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancerKush Dalal, Fuqiang Ban, Huifang Li, et al.Molecular Cancer Therapeutics|August 5, 2017
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin InteractionsKush Dalal, Meixia Che, Nanette S Que, et al.Molecular Cancer Therapeutics|October 22, 2016
Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and ActivationNada Lallous, Eric Leblanc, Ravi S N Munuganti, et al.Pageof 2